GoldMining Inc
GOLD
Shopify Inc
SHOP
Celestica Inc
CLS
4
GoldMoney Inc
XAU
5
Andlauer Healthcare Group Inc
AND
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 57.28%324M | -28.48%113M | 92.16%98M | 1,300.00%12M | 5,150.00%101M | 1,314.32%206M | 1,435.56%158M | 84.94%51M | -106.11%-1M | 89.01%-2M |
Net income from continuing operations | 138.55%32M | 115.79%15M | 650.00%30M | 350.00%5M | -280.00%-18M | -11.60%-83M | -58.65%-95M | 116.67%4M | -119.30%-2M | 3,483.36%10M |
Operating gains losses | -142.86%-6M | -80.00%3M | ---17M | 400.00%3M | --5M | 486.35%14M | 659.17%15M | ---- | -101.02%-1M | ---- |
Depreciation and amortization | -6.57%185M | -11.76%45M | -9.43%48M | 2.13%48M | -6.38%44M | 109.47%198M | 9.62%51M | 234.09%53M | 174.55%47M | 168.06%47M |
Asset impairment expenditure | -98.48%1M | -98.46%1M | --0 | --0 | ---- | 81.94%66M | 6,951.96%65M | --0 | 269.21%1M | ---- |
Remuneration paid in stock | 383.33%29M | 1,700.00%16M | --5M | -60.00%2M | 200.00%6M | -49.62%6M | -111.58%-1M | --0 | 341.57%5M | -38.33%2M |
Deferred tax | -187.50%-23M | -154.55%-6M | 76.92%-3M | 66.67%5M | -111.11%-19M | -432.55%-8M | 82.85%11M | -442.86%-13M | 301.33%3M | -4,455.09%-9M |
Change In working capital | 715.38%106M | -65.18%39M | 400.00%35M | 5.56%-51M | 259.62%83M | 124.74%13M | 1,085.68%112M | 600.81%7M | -637.55%-54M | -34.53%-52M |
-Change in receivables | -466.67%-11M | 122.73%49M | -229.41%-22M | 0.00%-29M | 10.00%-9M | 102.19%3M | 137.42%22M | 641.43%17M | -20.35%-29M | 82.53%-10M |
-Change in inventory | 271.43%36M | 126.67%34M | --7M | 95.65%-1M | 69.23%-4M | 63.78%-21M | 357.00%15M | --0 | -1,770.59%-23M | 29.04%-13M |
-Change in prepaid assets | 280.00%9M | 150.00%6M | -33.33%-4M | 133.33%2M | -68.75%5M | 80.72%-5M | -43.90%-12M | 80.41%-3M | -137.30%-6M | 14,168.11%16M |
-Change in payables and accrued expense | 180.00%16M | -137.04%-64M | 675.00%46M | -103.13%-1M | 240.00%35M | -140.61%-20M | -266.78%-27M | -233.02%-8M | 334.35%32M | -207.09%-25M |
-Change in other current assets | 200.00%2M | --0 | --0 | --0 | --2M | ---2M | ---2M | --0 | --0 | --0 |
-Change in other current liabilities | -200.00%-6M | --0 | --0 | --0 | ---6M | --6M | --6M | --0 | --0 | --0 |
-Change in other working capital | 15.38%60M | -87.27%14M | 700.00%8M | 21.43%-22M | 400.00%60M | -56.31%52M | 142.22%110M | -98.01%1M | -365.17%-28M | -248.54%-20M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 57.28%324M | -28.48%113M | 92.16%98M | 1,300.00%12M | 5,150.00%101M | 1,314.32%206M | 1,435.56%158M | 84.94%51M | -106.11%-1M | 89.01%-2M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 50.42%-59M | 25.93%-20M | 40.00%-15M | 50.00%-17M | 78.79%-7M | -473.44%-119M | -167.73%-27M | -690.29%-25M | -28,004.47%-34M | -144.00%-33M |
Net PPE purchase and sale | -60.00%-16M | ---5M | -33.33%-4M | 52.38%-10M | 54.55%-15M | 86.36%-10M | --0 | 77.10%-3M | -135.97%-21M | -1,098.00%-33M |
Net intangibles purchas and sale | 60.00%-2M | 0.00%-1M | --0 | 50.00%-1M | --0 | ---5M | ---1M | --0 | ---2M | ---2M |
Net investment purchase and sale | --0 | 94.74%-1M | 66.67%-2M | ---3M | --6M | ---25M | ---19M | ---6M | --0 | --0 |
Net other investing changes | 48.10%-41M | -85.71%-13M | 43.75%-9M | 72.73%-3M | 0.00%2M | -964.46%-79M | 21.80%-7M | -183.86%-16M | -217.23%-11M | 118.57%2M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 50.42%-59M | 25.93%-20M | 40.00%-15M | 50.00%-17M | 78.79%-7M | -473.44%-119M | -167.73%-27M | -690.29%-25M | -28,004.47%-34M | -144.00%-33M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -76.51%-263M | 28.24%-94M | -225.71%-114M | 188.46%23M | -281.40%-78M | -1,805.95%-149M | -960.46%-131M | -15,962.18%-35M | -236.26%-26M | 3,776.09%43M |
Net issuance payments of debt | -84.67%-253M | 28.91%-91M | -239.39%-112M | 223.81%26M | -268.89%-76M | -262.38%-137M | -258.41%-128M | -1,982.78%-33M | -412.10%-21M | 623.05%45M |
Cash dividends paid | 0.00%-9M | 0.00%-2M | 0.00%-2M | 0.00%-3M | 0.00%-2M | -36.19%-9M | -18.32%-2M | -22.00%-2M | -72.42%-3M | -11.37%-2M |
Proceeds from stock option exercised by employees | 0.00%1M | --0 | --0 | --1M | ---- | 422.00%1M | --0 | --1M | --0 | ---- |
Net other financing activities | 50.00%-2M | 0.00%-1M | ---- | 50.00%-1M | ---- | 94.22%-4M | 98.44%-1M | -201.89%-1M | -5.75%-2M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -76.51%-263M | 28.24%-94M | -225.71%-114M | 188.46%23M | -281.40%-78M | -1,805.95%-149M | -960.46%-131M | -15,962.18%-35M | -236.26%-26M | 3,776.09%43M |
Net cash flow | ||||||||||
Beginning cash position | -49.20%95M | -21.49%95M | -4.55%126M | -43.30%110M | -49.20%95M | 46.91%187M | -16.76%121M | 22.74%132M | 87.65%194M | 35.14%187M |
Current changes in cash | 103.23%2M | ---1M | -244.44%-31M | 129.51%18M | 100.00%16M | -212.39%-62M | --0 | -128.49%-9M | -796.13%-61M | 126.14%8M |
Effect of exchange rate changes | 83.33%-5M | 92.31%-2M | --0 | -100.00%-2M | 0.00%-1M | -762.26%-30M | -902.18%-26M | -132.17%-2M | -150.08%-1M | 6.27%-1M |
End cash Position | -3.16%92M | -3.16%92M | -21.49%95M | -4.55%126M | -43.30%110M | -49.19%95M | -49.19%95M | -16.76%121M | 15.64%132M | 81.81%194M |
Free cash from | 65.41%306M | -29.61%107M | 100.00%94M | 103.70%1M | 271.43%84M | 361.35%185M | 339.80%152M | 600.10%47M | -607.89%-27M | -133.93%-49M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.